http://orcid.org/0000-0002-6831-0588
References
- Long B, Koyfman A. Controversies in the diagnosis of subarachnoid haemorrhage. J Emerg Med. 2016;50(6):839–847.
- Martin SC, Teo MK, Young AM, et al. Defending a traditional practice in the modern era: the use of lumbar puncture in the investigation of subarachnoid haemorrhage. Br J Neurosurg. 2015;29(6):799–803.
- Kronholm V, Lintrup J. Spectrophotometric investigations of the cerebrospinal fluid in the near-ultraviolet region. Acta Psychiatr Scand. 1960;35(3):314–329.
- Kjellin KG, Söderström CE. Diagnostic significance of CSF spectrophotometry in cerebrovascular diseases. J Neurol Sci. 1974;23(3):359–369.
- Linn FH1, Voorbij HA, Rinkel GJ, et al. Visual inspection versus spectrophotometry in detecting bilirubin in cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 2005;76(10):1452–1454.
- Chalmers AH. Cerebrospinal fluid xanthochromia testing simplified. Clin Chem. 2001;47(1):147–148.
- Chalmers AH1, Kiley M. Detection of xanthochromia in cerebrospinal fluid. Clin Chem. 1998;44(8 Pt 1):1740–1742.
- Okada H, Kawada K, Itoh S, et al. Effects of bilirubin photoisomers on the measurement of direct bilirubin by the bilirubin oxidase method. Ann Clin Biochem. 2018;55(2):276–280.
- Brodersen R. Bilirubin. Solubility and interaction with albumin and phospholipid. J Biol Chem. 1979;254(7):2364–2369.
- Jasprova J, Dal Ben M, Vianello E, et al. The biological effects of bilirubin photoisomers. PLoS One. 2016;11(2):e0148126.
- Cruickshank A, Auld P, Beetham R, et al. Revised national guidelines for analysis of cerebrospinal fluid for bilirubin in suspected subarachnoid haemorrhage. Ann Clin Biochem. 2008;45(3):238–244.
- Reviewed By Ainsley H. Chalmers. Comments on the Proposed National Guidelines for Analysis of Cerebrospinal Fluid for Bilirubin in Suspected Subarachnoid Haemorrhage. Produced by a working group of UK NEQAS for Immunochemistry and in conjunction with the National Audit Group of the Association of Clinical Biochemists. Clin Biochem Rev. 2003;24(4):131–133.
- UK National External Quality Assessment Scheme for Immunochemistry Working Group. National guidelines for analysis of cerebrospinal fluid for bilirubin in suspected subarachnoid haemorrhage. Ann Clin Biochem. 2003;40:481–488.
- Inui T, Mase M, Shirota R, et al. Lipocalin-type prostaglandin D synthase scavenges biliverdin in the cerebrospinal fluid of patients with aneurysmal subarachnoid haemorrhage. J Cereb Blood Flow Metab. 2014;34(9):1558–1567.
- Petzold A, Sharpe LT, Keir G. Spectrophotometry for cerebrospinal fluid pigment analysis. NCC. 2006;4(2):153–162.
- Nagy K, Skagervik I, Tumani H, et al. Cerebrospinal fluid analyses for the diagnosis of subarachnoid haemorrhage and experience from a Swedish study. What method is preferable when diagnosing a subarachnoid haemorrhage? Clin Chem Lab Med. 2013;51(11):2073–2086.
- Grimmig B, Kim SH, Nash K, et al. Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration. Geroscience. 2017;39(1):19–32.
- Viljoen A, Walker SW, Walker KS, et al. Imprecision of cerebrospinal fluid net bilirubin absorbance. Clin Chem. 2004;50(7):1266–1268.
- Beetham R. CSF spectrophotometry for bilirubin–why and how? Scand J Clin Lab Invest. 2009;69(1):1–7.
- Cruickshank AM. ACP Best Practice No 166: CSF spectrophotometry in the diagnosis of subarachnoid haemorrhage. J Clin Pathol. 2001;54(11):827–830.
- Griffiths MJ, Chow E, Panting MD, et al. Comparison of original (2003) and revised (2008) national guidelines for reporting of cerebrospinal fluid spectrophotometric scanning for suspected subarachnoid haemorrhage against patient outcome. Ann Clin Biochem. 2010;47(4):375–377.